Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a minor version update: v3.4.2 added and v3.4.1 removed, with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe University of Texas MD Anderson Cancer Center is renamed to M.D. Anderson Cancer Center in the locations list, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check28 days agoChange DetectedThe page now includes a glossary display option, a new 'Last Update Submitted that Met QC Criteria' label, and a revision indicator (Revision: v3.4.0), while previous wording variants for QC status and FEAR Act data were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page shows a technical revision update from v3.3.3 to v3.3.4 without changes to study details or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations were added and state-specific location sections were reorganized; the page now presents trial sites by state (CA, DC, FL, MI, MN, MO, NY, NC, OR, PA) under Locations. The HHS Vulnerability Disclosure link was removed and the revision label updated from v3.3.2 to v3.3.3.SummaryDifference1%

- Check93 days agoChange DetectedPublications section now states that PubMed-derived publications are automatically filled and may not be about the study. The page revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.